Nebraska Heart Institute — Grand Island, Nebraska

Nebraska Heart Institute is a clinical research site located in Grand Island, Nebraska, United States 68803.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Heart Institute has participated in 3 clinical trials.

Therapeutic areas: Anti-coagulation Therapy, DVT, Pulmonary Embolism.

Sponsors: Iverson Genetic Diagnostics, Inc., Zoll Medical Corporation, Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Heart Institute?

Nebraska Heart Institute has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Heart Institute conducted?

Nebraska Heart Institute has 3 clinical trials on record. Their work covers Anti-coagulation Therapy, DVT, Pulmonary Embolism.

Is Nebraska Heart Institute accredited by Crixeo Health?

Nebraska Heart Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Heart Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.